Yoshihiro Banno

Discovery of [<i>cis</i>-3-({(5<i>R</i>)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5<i>H</i>)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist

Mitsunori Kono, Atsuko Ochida, Tsuneo Oda et al. · Journal of Medicinal Chemistry · 2018 · 62 citations

Pharmacotherapy, Pharmaceutical Chemistry, Pre-clinical Pharmacology +16

Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor

Yasufumi Miyamoto, Yoshihiro Banno, Tatsuhiko Fujimoto et al. · Journal of Medicinal Chemistry · 2011 · 54 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Pharmacotherapy +16

Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554

Yoshihiro Banno, Yasufumi Miyamoto, Mitsuru Sasaki et al. · Bioorganic & Medicinal Chemistry · 2011 · 42 citations · Full text

Medicinal Chemistry, Unique Interaction, Bioorganic Chemistry +10

Reactions of alkynylselenonium salts with sodium benzenesulfinate

Tadashi Kataoka, Yoshihiro Banno, Shinichi Watanabe et al. · Tetrahedron Letters · 1997 · 42 citations

Organic Chemistry, Sodium Benzenesulfinate, Chemistry +1

Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist

Tatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda et al. · ACS Medicinal Chemistry Letters · 2022 · 32 citations · Full text